Bliss GVS Pharma Limited reported unaudited standalone and consolidated earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, the company reported total income from operations of INR 735.928 million compared to INR 891.626 million a year ago. Profit before exceptional items and tax was INR 171.629 million compared to INR 249.874 million a year ago. Profit before tax was INR 171.629 million compared to INR 249.874 million a year ago. Net profit for the period was INR 104.021 million or INR 1.01 per basic and diluted share compared to INR 162.208 million or INR 1.57 per basic and diluted share a year ago. For the nine months, the company reported total income from operations of INR 2,149.755 million compared to INR 2,528.514 million a year ago. Profit before exceptional items and tax was INR 571.812 million compared to INR 760.367 million a year ago. Profit before tax was INR 571.812 million compared to INR 760.367 million a year ago. Net profit for the period was INR 367.015 million or INR 3.55 per basic and diluted share compared to INR 503.811 million or INR 4.88 per basic and diluted share a year ago. For the quarter, the consolidated company reported total income from operations of INR 1,959.225 million compared to INR 2,338.658 million a year ago. Profit before exceptional items and tax was INR 391.160 million compared to INR 380.071 million a year ago. Profit before tax was INR 391.160 million compared to INR 380.071 million a year ago. Net profit for the period was INR 259.833 million or INR 2.10 per basic and diluted share compared to INR 215.416 million or INR 2.02 per basic and diluted share a year ago. For the nine months, the consolidated company reported total income from operations of INR 6,480.396 million compared to INR 5,439.703 million a year ago. Profit before exceptional items and tax was INR 1,467.337 million compared to INR 1,150.075 million a year ago. Profit before tax was INR 1,467.337 million compared to INR 1,150.075 million a year ago. Net profit for the period was INR 1,023.827 million or INR 9.82 per basic and diluted share compared to INR 700.836 million or INR 7.47 per basic and diluted share a year ago.